迈瑞医疗
(300760)
| 流通市值：3449.39亿 | | | 总市值：3449.40亿 |
| 流通股本：12.12亿 | | | 总股本：12.12亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 27,303,797,964 | 18,475,773,496 | 8,364,281,841 | 30,365,643,811 |
| 营业收入 | 27,303,797,964 | 18,475,773,496 | 8,364,281,841 | 30,365,643,811 |
| 二、营业总成本 | 16,548,221,666 | 11,451,529,589 | 5,572,679,803 | 19,826,760,259 |
| 营业成本 | 9,251,094,921 | 6,356,227,937 | 2,810,679,041 | 10,885,289,458 |
| 税金及附加 | 288,037,305 | 185,206,248 | 84,671,723 | 348,286,018 |
| 销售费用 | 3,989,365,767 | 2,834,582,023 | 1,373,819,628 | 4,801,555,324 |
| 管理费用 | 1,115,793,687 | 795,641,115 | 457,084,878 | 1,320,052,334 |
| 研发费用 | 2,508,923,742 | 1,851,429,618 | 852,300,844 | 2,922,614,427 |
| 财务费用 | -604,993,756 | -571,557,352 | -5,876,311 | -451,037,302 |
| 其中:利息费用 | 8,818,027 | 5,545,091 | 2,600,912 | 10,686,780 |
| 其中:利息收入 | 526,335,326 | 292,212,391 | 138,435,482 | 357,905,784 |
| 加:公允价值变动收益 | 60,837,032 | 33,176,206 | - | -21,378,189 |
| 加:投资收益 | -4,950,533 | -1,797,920 | -1,091,341 | -5,061,416 |
| 资产处置收益 | 4,319,764 | -113,618 | -594,324 | 6,164,292 |
| 资产减值损失(新) | -120,053,114 | -76,853,744 | -42,555,992 | -71,094,102 |
| 信用减值损失(新) | -60,415,250 | -56,868,456 | -47,319,982 | -36,814,207 |
| 其他收益 | 565,377,484 | 408,181,672 | 199,644,189 | 579,815,101 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 11,200,691,681 | 7,329,968,047 | 2,899,684,588 | 10,990,515,031 |
| 加:营业外收入 | 36,129,071 | 18,176,959 | 9,074,442 | 35,283,143 |
| 减:营业外支出 | 49,837,637 | 38,353,604 | 21,158,655 | 72,247,521 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 11,186,983,115 | 7,309,791,402 | 2,887,600,375 | 10,953,550,653 |
| 减:所得税费用 | 1,351,457,445 | 866,578,823 | 315,261,372 | 1,342,833,838 |
| 六、净利润 | 9,835,525,670 | 6,443,212,579 | 2,572,339,003 | 9,610,716,815 |
| 持续经营净利润 | 9,835,525,670 | 6,443,212,579 | 2,572,339,003 | 9,610,716,815 |
| 归属于母公司股东的净利润 | 9,834,303,940 | 6,441,990,849 | 2,571,117,273 | 9,607,174,094 |
| 少数股东损益 | 1,221,730 | 1,221,730 | 1,221,730 | 3,542,721 |
| (一)基本每股收益 | 8.12 | 5.32 | 2.13 | 7.94 |
| (二)稀释每股收益 | 8.12 | 5.32 | 2.12 | 7.94 |
| 八、其他综合收益 | 199,121,815 | 322,167,973 | 5,136,437 | 300,670,248 |
| 归属于母公司股东的其他综合收益 | 199,121,815 | 322,167,973 | 5,136,437 | 300,670,248 |
| 九、综合收益总额 | 10,034,647,485 | 6,765,380,552 | 2,577,475,440 | 9,911,387,063 |
| 归属于母公司股东的综合收益总额 | 10,033,425,755 | 6,764,158,822 | 2,576,253,710 | 9,907,844,342 |
| 归属于少数股东的综合收益总额 | 1,221,730 | 1,221,730 | 1,221,730 | 3,542,721 |
| 公告日期 | 2023-10-28 | 2023-08-30 | 2023-04-28 | 2023-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |